ATC Group: C10AD Nicotinic acid and derivatives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C10AD in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C10 Lipid modifying agents
3 C10A Lipid modifying agents, plain
4 C10AD Nicotinic acid and derivatives

Group C10AD contents

Code Title
C10AD01 Niceritrol
C10AD02 Nicotinic acid
C10AD03 Nicofuranose
C10AD04 Aluminium nicotinate
C10AD05 Nicotinyl alcohol (pyridylcarbinol)
C10AD06 Acipimox
C10AD52 Nicotinic acid, combinations

Active ingredients in C10AD

Active Ingredient Description
Acipimox

Acipimox inhibits the release of fatty acids from adipose tissue and reduces the blood concentrations of very low density lipoproteins (VLDL or Pre-beta) and low density lipoproteins (LDL or beta) with a subsequent overall reduction in triglyceride and cholesterol levels.

Niceritrol
Nicotinic acid

Niacin (nicotinic acid) is an essential B complex Vitamin (B3), whose deficiency results in the clinical syndrome known as pellagra. Nicotinamide (niacinamide), the active ingredient, is the physiologically active form of niacin and is the chemical form of Vitamin B3 found in virtually all multivitamin products. Though nicotinic acid and nicotinamide are so closely related chemically, they differ somewhat in pharmacological properties.

Related product monographs

Title Information Source Document Type  
NIASPAN Film coated tablet / Extended-release tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
OLBETAM Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC